Efficiently Generating Japan-Specific Clinical Data to Streamline CDx Approval & Develop Efficacious, Tolerable Precision Therapies
- Generating Japan-relevant clinical data aligned with PMDA requirements for optimized CDx approval
- Coordinating CDx–drug development strategies to bring safe, effective precision therapies to patients in Japan